|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-10-28
|
|
pubmed:abstractText |
This randomized clinical trial is designed to assess whether the prevention and/or correction of anemia, by immediate versus delayed treatment with erythropoietin alfa in patients with chronic kidney disease, would delay left ventricular (LV) growth. Study design and sample size calculations were based on previously published Canadian data.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:BarrePaulP,
pubmed-author:BarrettBrendanB,
pubmed-author:CarlisleEuanE,
pubmed-author:DjurdjevOgnjenkaO,
pubmed-author:EthierJeanJ,
pubmed-author:HollandDavidD,
pubmed-author:KappelJoanneJ,
pubmed-author:LevinAdeeraA,
pubmed-author:MagnerPeterP,
pubmed-author:MuirheadNormanN,
pubmed-author:PichetteVincentV,
pubmed-author:ShokerAhmedA,
pubmed-author:SingerJoelJ,
pubmed-author:SoltysGeorgeG,
pubmed-author:TamPaulP,
pubmed-author:ThompsonChristopherC,
pubmed-author:TobeSheldonS,
pubmed-author:VerrelliMauroM,
pubmed-author:WadgymarJose ArturoJA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
799-811
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16253719-Adult,
pubmed-meshheading:16253719-Aged,
pubmed-meshheading:16253719-Anemia,
pubmed-meshheading:16253719-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16253719-Antihypertensive Agents,
pubmed-meshheading:16253719-Calcium,
pubmed-meshheading:16253719-Canada,
pubmed-meshheading:16253719-Chronic Disease,
pubmed-meshheading:16253719-Erythropoietin,
pubmed-meshheading:16253719-Female,
pubmed-meshheading:16253719-Heart Failure,
pubmed-meshheading:16253719-Heart Ventricles,
pubmed-meshheading:16253719-Hemoglobins,
pubmed-meshheading:16253719-Humans,
pubmed-meshheading:16253719-Hypertension,
pubmed-meshheading:16253719-Hypertrophy, Left Ventricular,
pubmed-meshheading:16253719-Kidney Diseases,
pubmed-meshheading:16253719-Lipids,
pubmed-meshheading:16253719-Male,
pubmed-meshheading:16253719-Middle Aged,
pubmed-meshheading:16253719-Organ Size,
pubmed-meshheading:16253719-Parathyroid Hormone,
pubmed-meshheading:16253719-Phosphates,
pubmed-meshheading:16253719-Recombinant Proteins,
pubmed-meshheading:16253719-Renal Dialysis,
pubmed-meshheading:16253719-Single-Blind Method,
pubmed-meshheading:16253719-Treatment Failure
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.
|
|
pubmed:affiliation |
University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada. alevin@providencehealth.bc.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
